ChristopherRHarmanMD

Birth Defect & Fetal Treatment, Maternal & Fetal Medicine/High Risk

Center for Advanced Fetal Care University of Maryland Medical Center

Dr. Harman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
419 W Redwood St
Ste 500
Baltimore, MD 21201
Phone+1 410-328-0253

Fax+1 410-328-3379

PubMed

58 citations
Prevalence of viral DNA in amniotic fluid of low-risk pregnancies in the second trimester
Ahmet Baschat, Jeffrey A. Towbin, Neil E. Bowles, Christopher Harman, Carl P. Weiner
The Journal of Maternal-Fetal & Neonatal Medicine. 2003-06-01
37 citations
Antenatal prediction of intraventricular hemorrhage in fetal growth restriction: what is the role of Doppler?
Ahmet Baschat, Ulrich Gembruch, Rose M. Viscardi, Ludwig Gortner, Christopher Harman
Ultrasound in Obstetrics & Gynecology. 2002-04-01
24 citations
Technical factors in early amniocentesis predict adverse outcome. Results of the Canadian Early (EA) versus Mid-trimester (MA) Amniocentesis Trial.
Jo-Ann Johnson, R. D. Wilson, J. Singer, Elizabeth J.T. Winsor, Christopher Harman
Prenatal Diagnosis. 1999-08-01

Find Mothers’ Diabetes May Induce Premature Aging of Neural Tissue in Early Development of Fetuses, Leading to Birth DefectsSeptember 9th, 2021
High Diagnosis Rate for Nonimmune Hydrops Fetalis with Prenatal Clinical Exome from the Hydrops-Yielding Diagnostic Results of Prenatal Sequencing (HYDROPS) StudyMarch 8th, 2021
UM SOM Names Deputy Director of Graduate and Postdoctoral Studies for Its Graduate Program in Life SciencesAugust 9th, 2017